PDS Biotechnology Corporation (PDSB) Financials

PDSB Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 57.2 million 32.7 million
2023-06-30 63.8 million 31.3 million
2023-03-31 68.4 million 27.4 million
2022-12-31 77.0 million 33.0 million

PDSB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.2 million 2.1 million
2023-06-30 -4.8 million 2.1 million
2023-03-31 -13.2 million 2.1 million
2022-12-31 -7.5 million 1.4 million

PDSB Net Income

No data available :(

PDSB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 54.3 million - 191938
2023-06-30 60.6 million 23.3 million 264464
2023-03-31 65.2 million 23.1 million 364380
2022-12-31 73.8 million 23.0 million 452054

PDSB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 30.9 million
2023-06-30 30.8 million
2023-03-31 30.4 million
2022-12-31 28.6 million

PDSB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 6.4 million 4.1 million -
2023-06-30 - 8.0 million 4.7 million -
2023-03-31 - 5.8 million 3.6 million -
2022-12-31 - 16.2 million 2.7 million -

PDSB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 14403
2023-06-30 - 74663
2023-03-31 - 74369
2022-12-31 - 11575

PDSB

Price: $3.82

52 week price:
2.59
10.27

Earnings Per Share: -1.39 USD

P/E Ratio: -3.20

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 392200

Market Capitalization: 140.1 million

Links: